source
- Sequencing Strategies After Progression in Multiple Myelomaonclive · 2mo ago↗ source
- EGFR-Mutated NSCLC: Targeting MET-Driven Resistance in Second-Line TherapyIn this segment, Dr. Sands asks Dr. Wakelee to discuss how emerging data on MET-driven resistance mechanisms are shaping second-line treatment decisions in EGFR-mutated non-small cell lung cancer.onclive · 2mo ago↗ source
- Sequencing ADCs in Endometrial CancerSequencing therapy in recurrent endometrial cancer is becoming more complicated as immunotherapy moves earlier and antibody drug conjugates gain momentum.onclive · 2mo ago↗ source